14.01.2015 Views

SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists

SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists

SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

F9 <br />

ESTIMA TE OF DETECTION PERIOD IN URINE FOR MARKERS OF STREET HEROIN<br />

Sue Paterson*, Rosa Cordero, Simon Burlinson<br />

Toxicology Unit, Imperial College London, St Dunstan's Road, London W6 8RP, UK<br />

Nick Lintzeris<br />

National Addiction Centre, 4 Windsor Walk, London SE5, UK<br />

There is growing international interest in prescribed pharmaceutical heroin as treatment for individuals who<br />

are unable to stop injecting opiate drugs. The rationale for this treatment is one <strong>of</strong> "harm minimisation". In<br />

a previous paper (1) co-workers reported on the GC-MS analysis <strong>of</strong> over 1000 urine samples from patients<br />

attending a substance misuse service during which metabolites <strong>of</strong> various contaminants <strong>of</strong> street heroin<br />

were detected. They concluded that the detection <strong>of</strong> papaverine and noscapine metabolites was likely to<br />

provide a reasonably sensitive and highly specific means <strong>of</strong> identifying the illicit use <strong>of</strong> heroin in patients<br />

prescribed diamorphine. We believe that these markers <strong>of</strong>fer the best means <strong>of</strong> determining the use <strong>of</strong> street<br />

heroin in these patients. The aim <strong>of</strong> this study was to estimate the detection period for identifying markers<br />

in the urine <strong>of</strong> street heroin users. Over 50 urine samples were collected from patients who admitted to the<br />

use <strong>of</strong> street heroin within the previous 72 hours. The researcher interviewed each subject regarding all<br />

episodes <strong>of</strong> drug use within the preceding 72 hours, including details <strong>of</strong> amount used, route <strong>of</strong><br />

administration and time <strong>of</strong> use. The time the urine was passed was also noted. These samples were analysed<br />

by the method currently in use for the routine analysis <strong>of</strong> urine samples from patients attending drug<br />

treatment centres, that is mixed-mode solid-phase extraction (SPE) followed by GC-MS (2). Urine samples<br />

were subjected to enzymatic hydrolysis followed by SPE using Bakerbond narc-2 columns. The eluent was<br />

selectively derivatised with N-methyl-bis-tritluoroacetamide and N-methyl-N-trimethylsilyltrifluoroacetamide<br />

+ 1% trimethylchlorosilane. Analysis was performed using a GC-MS system operating in full<br />

scan mode. The study samples were analysed for the commonly abused drugs plus a range <strong>of</strong> other drugs<br />

including antidepressants and certain anti psychotics that are prescribed to these patients. In addition, the<br />

metabolites <strong>of</strong> papaverine, hydroxy and dihydroxypapaverine, and the metabolites <strong>of</strong> noscapine, meconine<br />

and hydroxymeconine, were looked for in each sample. Other contaminants <strong>of</strong> street heroin including<br />

papaverine, noscapine, thebaine, and acetylcodeine were also monitored. Using this assay the limit <strong>of</strong><br />

detection for morphine was 0.05 ugimL. The limit <strong>of</strong> detection for hydroxy and dihydroxypapaverine could<br />

not be determined as pure standards were not commercially available. A characteristic peak pattern in the<br />

chromatogram was found to be indicative <strong>of</strong> the presence <strong>of</strong> the papaverine metabolites, which were then<br />

matched by retention time and spectra obtained from the elucidation <strong>of</strong> these metabolite derivatives as<br />

reported previously (1). Initial analysis <strong>of</strong> the data shows that hydroxy and dihydroxpapaverine were<br />

detected in urine for approximately the same period as morphine. This data supports the findings <strong>of</strong><br />

McLachlan-Troup et al that hydroxy and dihydroxypapaverine can be used to determine if patients<br />

prescribed injectable diamorphine are "topping-up" with street heroin. Papaverine, noscapine, thebaine and<br />

acetyl codeine were not detected in any <strong>of</strong> the study samples.<br />

l. N, McLachlan-Troup, G.W. Taylor, B.c. Trathen. Diamorphine treatment for opiate dependence:<br />

putative markers <strong>of</strong> concomitant heroin misuse. Addiction Biology, 2001; 6: 223-231<br />

2. S Paterson, R Cordero, S McCulloch, P Houldsworth. Analysis <strong>of</strong> urine for drugs <strong>of</strong> abuse using mixedmode<br />

solid-phase extraction and gas chromatography/mass spectrometry. Ann. Ojefin. Biochem. 2000; 37:<br />

690-700.<br />

Keywords: Street heroin markers, papaverine metabolites, noscapine metabolites<br />

Page 262

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!